ACE2 and COVID-19: Though it is established that SARS-CoV-2 is able to infect the CNS, it remains unknown if the neurological issues observed in COVID-19 patients are due to direct viral binding to ACE2 in the brain or to the cytokine storm causing systemic hyperinflammation, including neuroinflammation [36,48].